Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  05/26/2010
 
Trade Name:  Nasonex
 
Generic Name or Proper Name (*):  mometasone
 
Indications Studied:  Nasal congestion associated with seasonal allergic rhinitis
 
Label Changes Summary:  New indication in pediatric patients 2 years and older Safety and effectiveness evaluated in 3 clinical studies in 12 years and older. Use in pediatric patients 2 - 11 years is supported by data from other pediatric clinical studies Safety and effectiveness for any use in patients < 2 years have not been established Information on dosing, adverse reactions, and clinical studies in 12 years and older New indication
 
Product Labeling:  Labeling  Opens a new window
 
Sponsor:  Schering-Plough
 
NNPS:  FALSE'
 
Therapeutic Category:  Anti-inflammatory, topical
 
-
-